fbpx United Kingdom | Page 149 | Marijuana Business News | Cannabis Industry & Legalization | 420 Intel

United Kingdom


Cannabinoids Could Slow Parkinson’s, Study Explains Why

New research out of the UK may explain why chemicals from marijuana offer protection in various models of Parkinson’s disease.

Parkinson’s is more common among the aging population and is marked by a widespread loss of dopamine-producing cells in the brain.

However, investigators from the Peninsula Schools of Medicine and Dentistry at University of Plymouth say that numerous studies have found cannabinoids to protect cells from Parkinson’s-related damage.

Cannabinoids such as Δ9-tetrahydrocannabinol [THC] are neuroprotective in animal and cell culture models of Parkinson’s disease.

In the latest study, the team, led by Camille Carrol, Ph.D, identified a mechanism that appears to underlie these benefits.


A CLEAR Plan For The Regulation Of Cannabis In Britain


Download the IDMU report "Taxing the UK Cannabis Market" (PDF file)

CLEAR has published a report from the Independent Drug Monitoring Unit (IDMU) that shows a tax & regulate policy on cannabis could produce a net benefit to the UK economy of £6.7 billion per annum. This estimate is made from a detailed study of the size of the UK cannabis market, potential tax revenues, criminal justice system savings and additional costs of regulation including health information and education.


Legal Medicinal Cannabis In Britain ACHIEVED!

This is the most joyous news that I have dreamed of writing for years. Legal access to herbal medicinal cannabis in Britain has been achieved!

Following a procedure on which we have offered advice and guidance, a CLEAR member has returned to the UK from Holland with 90g of Bedrocan medicinal cannabis which was prescribed by his UK GP. He declared the medicine at customs, all 18 tubs containing five grams each were examined, he showed the various documentation which we have obtained and he was authorised to proceed.


Wonder drugs from ganja - Britain approves cannabis-based medicine

NEW DEVELOPMENTS in the production of legal drugs from marijuana in Britain has put the spotlight on the potential of ganja as a source of legitimate earnings here.

In a recent article in The Economist, it was disclosed that victims of multiple sclerosis (MS) since June 21 this year can legally purchase a marijuana-based medicine known as Sativex in Britain to alleviate the excruciating pain and spasms associated with their condition.


Subscribe to RSS - United Kingdom